PATENT CLAIM ANALYSIS

Application Number: 16030955
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "062000"]

Abstract:
Compositions and methods are provided for treating joint conditions, such as osteoarthritis and/or the pain associated therewith. The compositions and methods utilize a first component, namely hyaluronic acid (“HA”), in combination with a lyophilized second component that is effective to at least temporarily reduce the viscosity of the HA. In an exemplary embodiment, the second component is one or more glycosaminoglycans (“GAG”), such as chondroitin sulfate (“CS”), including CS4 and/or CS6, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. The composition can optionally include other joint supplements, such as glucosamine (“GlcN”)

Claim (Index 11):
The method of  claim 7 , wherein the hyaluronic acid is present in the mixture at a concentration between about 7 mg/ml and about 60 mg/ml by weight of the mixture.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 95.0
- Lexical Diversity: 1.61333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12979981', '13173658', '14600770', '15612267', '14559319']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7949656561212021
- 35 USC 102 Novelty (BERT): 0.5404042836857019
- Combined Prediction Score: 0.7695095188776521
- Mean Citation Score: 307.323526
- Max Citation Score: 385.4359
- Similarity Product: 288.0565220359802

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test